What were the results of the Heart Outcomes Prevention Evaluation (HOPE) Study?
The results of the Heart Outcomes Prevention Evaluation (HOPE) Study showed that ramipril had positive effects on cardiovascular and microvascular outcomes in people with diabetes mellitus. Specifically, the study found that ramipril was associated with a reduced risk of cardiovascular death, myocardial infarction, stroke, and other cardiovascular events, as well as improved microvascular outcomes, such as a reduction in the risk of diabetic nephropathy and retinopathy.